Niagen Bioscience (NAGE) Amortizatization of Intangibles (2019 - 2021)
Niagen Bioscience's (NAGE) quarterly Amortizatization of Intangibles came in at $131000.0 in Q3 2021, up 35.05% year-on-year from $97000.0 in Q3 2020, and up 35.05% on a QoQ basis from $97000.0 in Q3 2020.
Niagen Bioscience (NAGE) Amortizatization of Intangibles (2019 - 2021) Analysis & Trends
Niagen Bioscience (NAGE) has 3 years of Amortizatization of Intangibles data on file, last reported at $131000.0 in Q3 2021.
- On a quarterly basis, Amortizatization of Intangibles rose 35.05% year-over-year to $131000.0 in Q3 2021; TTM through Sep 2021 was $415000.0, a 10.37% increase from a year earlier, with the FY2019 full-year figure at $515000.0, changed N/A from the prior year.
- Amortizatization of Intangibles for Q3 2021 stood at $131000.0, up from $97000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for NAGE reached as high as $144000.0 in Q3 2019 and fell as low as $92000.0 in Q4 2019.
- Historically, Amortizatization of Intangibles has averaged $116250.0 across 3 years, with a median of $114000.0 in 2020.
- Across the five-year window, Amortizatization of Intangibles slumped 33.33% in 2020 and soared 35.05% in 2021, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $92000.0 in 2019, then gained by 5.43% to $97000.0 in 2020, then soared by 35.05% to $131000.0 in 2021.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $131000.0 in Q3 2021, $97000.0 in Q3 2020, and $95000.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Niagen Bioscience | 258.53 Mn | 191.98 Mn | 19.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 131,000.00 |
| Sep 30, 2021 | 131,000.00 |
| Sep 30, 2020 | 97,000.00 |
| Sep 30, 2020 | 97,000.00 |
| Jun 30, 2020 | 95,000.00 |
| Jun 30, 2020 | 95,000.00 |
| Mar 31, 2020 | 92,000.00 |
| Mar 31, 2020 | 92,000.00 |
| Dec 31, 2019 | 92,000.00 |
| Dec 31, 2019 | 92,000.00 |
| Sep 30, 2019 | 144,000.00 |
| Sep 30, 2019 | 144,000.00 |
| Jun 30, 2019 | 141,000.00 |
| Jun 30, 2019 | 141,000.00 |
| Mar 31, 2019 | 138,000.00 |
| Mar 31, 2019 | 138,000.00 |